![]() |
|
|
Vol. 30, Issue 4, 363-364, April 2002
| |
Abstract |
|---|
|
|
|---|
We found nucleotide variability in the 5'-upstream region and exonic sequences of a gene-encoding canalicular multispecific organic anion transporter/multidrug resistance-associated protein 2 (cMOAT/MRP2) by polymerase chain reaction-based sequencing using genomic DNA from 72 established cell lines derived from 72 Japanese individuals. Four single nucleotide polymorphisms (SNPs) were found in the 5'-untranslational region and 21 in the exonic regions. Of them, 14 were nonsynonymous SNPs. One deletion of seven consecutive adenines resulting in a frameshift variant was also found. Four SNPs, c-24t, g1249a (V417I), c2366t (S789F), and c3972t (I1324I), were the same as those recently reported. A strong association was found between c-24t (5'-untranslated region) and c3972t (exon 28), with the promoter activity of the former worth being compared.
| |
Introduction |
|---|
|
|
|---|
cMOAT/MRP2/ABCC2,
a member of ATP-binding cassette transporters, plays a primary
role in the active biliary excretion of organic anion compounds,
including glutathione and glucuronide conjugates and sulfated
conjugates of endogenous and exogenous substrates (Lautier et al.,
1996
; Loe et al., 1996
; Keppler and Konig, 1997
; Suzuki and Sugiyama,
1998
), and an anionic antitumor drug, such as irinotecan (CPT-11) and
its glucuronide (Chu et al., 1998
). Deficiency in human
cMOAT/MRP2/ABCC2 is known to be associated with Dubin-Johnson syndrome,
a hyperbilirubinemia caused by the lack of bilirubin excretion (Toh et
al., 1999
). These findings indicate the importance of human
cMOAT/MRP2/ABCC2 gene variants with functional changes. Ito et al.
(2001)
recently reported polymorphisms of the cMOAT/MRP2/ABCC2 gene
using 48 unrelated healthy Japanese subjects. In the present study, we
detected novel single nucleotide polymorphisms
(SNPs1) in genomic DNAs from 72 established cell
lines derived from Japanese individuals by a single polymerase chain
reaction for all the exons and the 5'-upstream region of
cMOAT/MRP2/ABCC2.
| |
Materials and Methods |
|---|
|
|
|---|
Cells and Culture Conditions. The 72 established cell lines used in the present study, which originated from different Japanese individuals, were purchased from the Health Science Research Resource Bank (Osaka, Japan) or the Japanese Collection of Research Bioresources (National Institute of Health Sciences, Tokyo, Japan). All of the cells originated from various tissues and were cultured according to the suppliers' instructions.
Sequence analyses of cMOAT/MRP2/ABCC2 Gene.
We sequenced approximately 800 base pairs of the 5'-upstream region
from the translation initiation codon and all of the 32 exons of the
cMOAT/MRP2/ABCC2 gene after performing a single polymerase chain
amplification reaction using multiplex primers, which are essentially
described by Toh et al. (1999)
. DNA that was extracted from the
cells was used as a template. The amplification and sequencing were
done as previously described (Nakamura et al., 2001
).
| |
Results and Discussion |
|---|
|
|
|---|
We sequenced the 800 base pairs of the 5'-upstream region
and all the exonic regions of the cMOAT/MRP2/ABCC2 gene. As for the
nucleotide position, the adenine of the translation initiation codon,
ATG, was set as the nucleotide position 1. Frequently appearing nucleotide variations (c-24t, g1249a, and c3972t) were consistently observed between the present study and the article by Ito et al. (2001)
. Three additional polymorphic sites were found in the
5'-upstream region, and 19 variations that were not reported by Ito et
al. (2001)
(Table 1) were detected in the
exons. Of those, 12 nucleotide changes were nonsynonymous, and the
frequency for c1457t (T486I) was approximately 0.03 (Table 1). In exon
8, a deletion of seven adenines was observed resulting in a frameshift.
A strong association was observed between the c-24t and c3972t
substitutions. The statistical analyses gave a
2 value of 106.6, with degrees of freedom of 4 and a p value less than 0.0001 using the program Prism 3.0 (GraphPad Software, San Diego, CA).
|
The amino acid substitutions S789F (c2366t) and S1367C
(c4100g) were reportedly located in nucleotide binding domains 1 and 2, respectively, those of V417I (g1249a) and T486I (c1457t) in membrane-spanning domain 2, and that of Q1019H (g3057t) in membrane spanning domain 3 (Toh et al., 1999
). Basic amino acids that have a key
functional role in drug transport have been identified for human MRP2
(Ryu et al., 2000
). None of the amino acid alterations in the present
study (Table 1) were found to be located within the Walker A, B, and C
motifs or to be the basic amino acids in the transmembrane domains
(TMs). It was strongly suggested that functional changes by the V417I,
S789F, D883N, Q1019H, N1244K, S1367C, and C1515Y alterations seemed to
be worth assessing because the TM1 to TM5 domains (200 N-terminal amino
acids) were dispensable for transportation of substrates (Ryu et al.,
2000
). In the SNP database of National Center for Biotechnology
Information, c-24t, c56t (P19L), and g4290t were registered with
accession numbers of rs717620, rs927344, and rs1137968, respectively,
indicating the usefulness of searching for possible novel SNPs from
established cell lines.
In the present study, we have found a number of novel SNPs, including nonsynonymous ones in the cMOAT/MRP2/ABCC2 gene of 72 cell lines of Japanese subjects. The c-24t associated with c3972t may be of importance in the regulation of the cMOAT/MRP2/ABCC2 gene.
Masaya Itoda
Yoshiro Saito
Akiko Soyama
Mayumi Saeki
Norie Murayama
Seiichi Ishida
Kimie Sai
Michiyo Nagano
Hiroshi Suzuki
Yuichi Sugiyama
Shogo Ozawa
Jun-ichi Sawada
Project Team for Pharmacogenetics
(M.I.,
Y.S., A.S., M.S., N.M., S.I., K.S., M.N.,
S.O., J.-i.S.),
Division of Biochemistry and Immunochemistry
(Y.S., J.-i.S.),
Division of Pharmacology
(S.I., S.O.),
Division of Xenobiotic
Metabolism and
Disposition (K.S.),
National Institute of
Health Sciences,
Setagaya-ku, Tokyo, Japan;
Graduate School of
Pharmaceutical Sciences
(H.S., Y.S.),
The University of
Tokyo,
Tokyo, Japan
| |
Acknowledgments |
|---|
We are grateful to all of the secretarial support by Kiyomi Okuyama.
| |
Footnotes |
|---|
Received July 31, 2001; accepted December 17, 2001.
This study was supported in part by the Program for Promotion of Fundamental Studies in Health Sciences (MPJ-6) of the Organization for Pharmaceutical Safety and Research of Japan.
Address correspondence to: Shogo Ozawa, Division of Pharmacology, NIHS, 1-18-1, Kamiyoga, Setagaya, Tokyo 158-8501, Japan. E-mail: sozawa{at}nihs.go.jp
| |
Abbreviations |
|---|
Abbreviations used are: SNP, single nucleotide polymorphism; TM, transmembrane domain; cMOAT/MRP2, canalicular multispecific organic anion transporter/multidrug resistance-associated protein 2.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
R. Nakagomi-Hagihara, D. Nakai, K. Kawai, Y. Yoshigae, T. Tokui, T. Abe, and T. Ikeda OATP1B1, OATP1B3, AND MRP2 ARE INVOLVED IN HEPATOBILIARY TRANSPORT OF OLMESARTAN, A NOVEL ANGIOTENSIN II BLOCKER Drug Metab. Dispos., May 1, 2006; 34(5): 862 - 869. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wojnowski, B. Kulle, M. Schirmer, G. Schluter, A. Schmidt, A. Rosenberger, S. Vonhof, H. Bickeboller, M. R. Toliat, E.-K. Suk, et al. NAD(P)H Oxidase and Multidrug Resistance Protein Genetic Polymorphisms Are Associated With Doxorubicin-Induced Cardiotoxicity Circulation, December 13, 2005; 112(24): 3754 - 3762. [Abstract] [Full Text] [PDF] |
||||
![]() |
C G Dietrich, A Geier, and R P J Oude Elferink ABC of oral bioavailability: transporters as gatekeepers in the gut Gut, December 1, 2003; 52(12): 1788 - 1795. [Full Text] [PDF] |
||||
![]() |
A. C. Lockhart, R. G. Tirona, and R. B. Kim Pharmacogenetics of ATP-binding Cassette Transporters in Cancer and Chemotherapy Mol. Cancer Ther., July 1, 2003; 2(7): 685 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nakajima, N. Sakata, N. Ohashi, T. Kume, and T. Yokoi Involvement of Multiple UDP-glucuronosyltransferase 1A Isoforms in Glucuronidation of 5-(4'-hydroxyphenyl)-5-phenylhydantoin in Human Liver Microsomes Drug Metab. Dispos., November 1, 2002; 30(11): 1250 - 1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Michalski, Y. Cui, A. T. Nies, A. K. Nuessler, P. Neuhaus, U. M. Zanger, K. Klein, M. Eichelbaum, D. Keppler, and J. Konig A Naturally Occurring Mutation in the SLC21A6 Gene Causing Impaired Membrane Localization of the Hepatocyte Uptake Transporter J. Biol. Chem., November 1, 2002; 277(45): 43058 - 43063. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||